Vycor Medical (VYCO) Depreciation & Amortization (CF) (2010 - 2026)

Vycor Medical (VYCO) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $15668.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 2.74% year-over-year to $15668.0 in Q1 2026; TTM through Mar 2026 was $62701.0, a 2.64% decrease from a year earlier, with the FY2025 full-year figure at $63143.0, down 1.2% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $15668.0, down from $16144.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for VYCO reached as high as $16869.0 in Q4 2024 and fell as low as $15021.0 in Q2 2025.
• Historically, Depreciation & Amortization (CF) has averaged $15580.9 across 5 years, with a median of $15563.0 in 2022.
• Across the five-year window, Depreciation & Amortization (CF) soared 39.43% in 2022 and slipped 4.3% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $15330.0 in 2022, then fell by 1.49% to $15102.0 in 2023, then rose by 11.7% to $16869.0 in 2024, then retreated by 4.3% to $16144.0 in 2025, then dropped by 2.95% to $15668.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $15668.0 in Q1 2026, $16144.0 in Q4 2025, and $15868.0 in Q3 2025.